© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 11, 874-897,
June 7, 2000
© 2000 Oxford University Press
REVIEW |
Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Affiliations of authors: M. Berwick, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY; P. Vineis, Unit of Cancer Epidemiology, University of Torino, and Ospedale S. Giovanni Battista, Torino, Italy.
Correspondence to: Marianne Berwick, Ph.D., Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., Box 588, New York, NY 10021 (e-mail: berwickm{at}mskcc.org).
DNA repair is a system of defenses designed to protect the integrity of the genome. Deficiencies in this system likely lead to the development of cancer. The epidemiology of DNA repair capacity and of its effect on cancer susceptibility in humans is, therefore, an important area of investigation. We have summarized all of the published epidemiologic studies on DNA repair in human cancer through 1998 (n = 64) that addressed the association of cancer susceptibility with a putative defect in DNA repair capacity. We have considered study design, subject characteristics, potential biases, confounding variables, and sources of technical variability. Assays of DNA repair capacity used, to date, can be broadly grouped into five categories: 1) tests based on DNA damage induced with chemicals or physical agents, such as the mutagen sensitivity assay, the G2-radiation assay, induced micronuclei, and the Comet assay; 2) indirect tests of DNA repair, such as unscheduled DNA synthesis; 3) tests based on more direct measures of repair kinetics, such as the host cell reactivation assay; 4) measures of genetic variation associated with DNA repair; and 5) combinations of more than one category of assay. The use of such tests in human populations yielded positive and consistent associations between DNA repair capacity and cancer occurrence (with odds ratios in the range of 1.4–75.3, with the majority of values between 2 and 10). However, the studies that we have reviewed have limitations, including small sample size, "convenience" controls, the use of cells different from the target organ, and the use of mutagens that do not occur in the natural environment. The evolving ability to study polymorphisms in DNA repair genes may contribute to new understandings about the mechanisms of DNA repair and the way in which DNA repair capacity affects the development of cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Gu, Y. Horikawa, M. Chen, C. P. Dinney, and X. Wu Benzo(a)pyrene Diol Epoxide-Induced Chromosome 9p21 Aberrations Are Associated with Increased Risk of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2445 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhang, W.-Y. Huang, G. Andreotti, Y.-T. Gao, A. Rashid, J. Chen, L. C. Sakoda, M.-C. Shen, B.-S. Wang, S. Chanock, et al. Variants of DNA Repair Genes and the Risk of Biliary Tract Cancers and Stones: A Population-Based Study in China Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2123 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhao, L.-E Wang, D. Li, R. M. Chamberlain, E. M. Sturgis, and Q. Wei Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis Carcinogenesis, August 1, 2008; 29(8): 1560 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Orlow, B. J. Park, U. Mujumdar, H. Patel, P. Siu-Lau, B. A. Clas, R. Downey, R. Flores, M. Bains, N. Rizk, et al. DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors J. Clin. Oncol., July 20, 2008; 26(21): 3560 - 3566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Capella, G. Pera, N. Sala, A. Agudo, F. Rico, G. Del Giudicce, M. Plebani, D. Palli, H. Boeing, H B. Bueno-de-Mesquita, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study Int. J. Epidemiol., July 19, 2008; (2008) dyn145v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Machella, M. B. Terry, J. Zipprich, I. Gurvich, Y. Liao, R. T. Senie, D. O. Kennedy, and R. M. Santella Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR Carcinogenesis, July 1, 2008; 29(7): 1367 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. El-Zein, M. Fenech, M. S. Lopez, M. R. Spitz, and C. J. Etzel Cytokinesis-Blocked Micronucleus Cytome Assay Biomarkers Identify Lung Cancer Cases Amongst Smokers Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1111 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Veglia, S. Loft, G. Matullo, M. Peluso, A. Munnia, F. Perera, D. H. Phillips, D. Tang, H. Autrup, O. Raaschou-Nielsen, et al. DNA adducts and cancer risk in prospective studies: a pooled analysis and a meta-analysis Carcinogenesis, May 1, 2008; 29(5): 932 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bhatti, A. J. Sigurdson, C. B. Thomas, A. Iwan, B. H. Alexander, D. Kampa, L. Bowen, M. M. Doody, and I. M. Jones No Evidence for Differences in DNA Damage Assessed before and after a Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wang, D. Chang, F.-l. Hu, H. Sui, B. Han, D.-d. li, and Y.-s. Zhao DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 507 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Hayden, P. Tewari, D. W. Morris, A. Staines, D. Crowley, A. Nieters, N. Becker, S. de Sanjose, L. Foretova, M. Maynadie, et al. Variation in DNA repair genes XRCC3, XRCC4, XRCC5 and susceptibility to myeloma Hum. Mol. Genet., December 15, 2007; 16(24): 3117 - 3127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.L. Crawford, T. Blomquist, D.N. Mullins, Y. Yoon, D.R. Hernandez, M. Al-Bagdhadi, J. Ruiz, J. Hammersley, and J.C. Willey CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions Carcinogenesis, December 1, 2007; 28(12): 2552 - 2559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Crew, M. D. Gammon, M. B. Terry, F. F. Zhang, L. B. Zablotska, M. Agrawal, J. Shen, C.-M. Long, S. M. Eng, S. K. Sagiv, et al. Polymorphisms in Nucleotide Excision Repair Genes, Polycyclic Aromatic Hydrocarbon-DNA Adducts, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2033 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chen, A. M. Kamat, M. Huang, H.B. Grossman, C. P. Dinney, S. P. Lerner, X. Wu, and J. Gu High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk Carcinogenesis, October 1, 2007; 28(10): 2160 - 2165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Waters, S. Shen, H. Xu, S. S. Kengeri, D. M. Cooley, E. C. Chiang, Y. Chen, D. Schlittler, C. Oteham, G. F. Combs Jr., et al. Noninvasive Prediction of Prostatic DNA Damage by Oxidative Stress Challenge of Peripheral Blood Lymphocytes Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1906 - 1910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zijno, F. Saini, and R. Crebelli Suitability of cryopreserved isolated lymphocytes for the analysis of micronuclei with the cytokinesis-block method Mutagenesis, September 1, 2007; 22(5): 311 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chen, Z. Hu, L.-E Wang, W. Zhang, A. K. El-Naggar, E. M. Sturgis, and Q. Wei Polymorphic TP53BP1 and TP53 Gene Interactions Associated with Risk of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., July 15, 2007; 13(14): 4300 - 4305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Manuguerra, G. Matullo, F. Veglia, H. Autrup, A.M. Dunning, S. Garte, E. Gormally, C. Malaveille, S. Guarrera, S. Polidoro, et al. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions Carcinogenesis, February 1, 2007; 28(2): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Paz-Elizur, R. Ben-Yosef, D. Elinger, A. Vexler, M. Krupsky, A. Berrebi, A. Shani, E. Schechtman, L. Freedman, and Z. Livneh Reduced Repair of the Oxidative 8-Oxoguanine DNA Damage and Risk of Head and Neck Cancer Cancer Res., December 15, 2006; 66(24): 11683 - 11689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Sak, J. H. Barrett, A. B. Paul, D. T. Bishop, and A. E. Kiltie Comprehensive Analysis of 22 XPC Polymorphisms and Bladder Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2537 - 2541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K. Kaufmann, L. Filatov, S. E. Oglesbee, D. A. Simpson, M. A. Lotano, H. D. McKeen, L. R. Sawyer, D. T. Moore, R. C. Millikan, M. Cordeiro-Stone, et al. Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk Carcinogenesis, December 1, 2006; 27(12): 2519 - 2527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, J. Gu, Q. Dong, M. Huang, K.-A. Do, W. K. Hong, and M. R. Spitz Joint Effect of Mutagen Sensitivity and Insulin-Like Growth Factors in Predicting the Risk of Developing Secondary Primary Tumors and Tumor Recurrence in Patients with Head and Neck Cancer Clin. Cancer Res., December 1, 2006; 12(23): 7194 - 7201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Chao, C. C. Maley, X. Wu, D. C. Farrow, P. C. Galipeau, C. A. Sanchez, T. G. Paulson, P. S. Rabinovitch, B. J. Reid, M. R. Spitz, et al. Mutagen Sensitivity and Neoplastic Progression in Patients with Barrett's Esophagus: A Prospective Analysis. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, M. Desai, M. Agrawal, D. O. Kennedy, R. T. Senie, R. M. Santella, and M. B. Terry Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1614 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Manuguerra, F. Saletta, M. R. Karagas, M. Berwick, F. Veglia, P. Vineis, and G. Matullo XRCC3 and XPD/ERCC2 Single Nucleotide Polymorphisms and the Risk of Cancer: A HuGE Review Am. J. Epidemiol., August 15, 2006; 164(4): 297 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Thirumaran, J. L. Bermejo, P. Rudnai, E. Gurzau, K. Koppova, W. Goessler, M. Vahter, G. S. Leonardi, F. Clemens, T. Fletcher, et al. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin Carcinogenesis, August 1, 2006; 27(8): 1676 - 1681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Miller, M. R. Karagas, P. Kraft, D. J. Hunter, P. J. Catalano, S. H. Byler, and H. H. Nelson XPA, haplotypes, and risk of basal and squamous cell carcinoma Carcinogenesis, August 1, 2006; 27(8): 1670 - 1675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, M. R. Spitz, C. I. Amos, J. Lin, L. Shao, J. Gu, M. de Andrade, N. L. Benowitz, P. G. Shields, and G. E. Swan Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res., June 15, 2006; 66(12): 5993 - 5996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. El-Zein, M. B. Schabath, C. J. Etzel, M. S. Lopez, J. D. Franklin, and M. R. Spitz Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res., June 15, 2006; 66(12): 6449 - 6456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, A.M. Dunning, S. Guarrera, C. Baynes, S. Polidoro, S. Garte, H. Autrup, C. Malaveille, M. Peluso, L. Airoldi, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study Carcinogenesis, May 1, 2006; 27(5): 997 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Patino-Garcia, J. Hoegel, D. Varga, M. Hoehne, I. Michel, S. Jainta, R. Kreienberg, C. Maier, and W. Vogel Scoring variability of micronuclei in binucleated human lymphocytes in a case-control study Mutagenesis, May 1, 2006; 21(3): 191 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Lubin and N. E. Caporaso Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 517 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Pachkowski, S. Winkel, Y. Kubota, J. A. Swenberg, R. C. Millikan, and J. Nakamura XRCC1 Genotype and Breast Cancer: Functional Studies and Epidemiologic Data Show Interactions between XRCC1 Codon 280 His and Smoking. Cancer Res., March 1, 2006; 66(5): 2860 - 2868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Millikan, A. Hummer, C. Begg, J. Player, A. R. de Cotret, S. Winkel, H. Mohrenweiser, N. Thomas, B. Armstrong, A. Kricker, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study Carcinogenesis, March 1, 2006; 27(3): 610 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A.S. Langie, A. M. Knaapen, K. J.J. Brauers, D. van Berlo, F.-J. van Schooten, and R. W.L. Godschalk Development and validation of a modified comet assay to phenotypically assess nucleotide excision repair Mutagenesis, March 1, 2006; 21(2): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Travis, C. S. Rabkin, L. M. Brown, J. M. Allan, B. P. Alter, C. B. Ambrosone, C. B. Begg, N. Caporaso, S. Chanock, A. DeMichele, et al. Cancer Survivorship--Genetic Susceptibility and Second Primary Cancers: Research Strategies and Recommendations J Natl Cancer Inst, January 4, 2006; 98(1): 15 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Matullo, S. Guarrera, C. Sacerdote, S. Polidoro, L. Davico, S. Gamberini, M. Karagas, G. Casetta, L. Rolle, A. Piazza, et al. Polymorphisms/Haplotypes in DNA Repair Genes and Smoking: A Bladder Cancer Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2569 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Collini, M. Caccia, G. Chirico, F. Barone, E. Dogliotti, and F. Mazzei Two-photon fluorescence cross-correlation spectroscopy as a potential tool for high-throughput screening of DNA repair activity Nucleic Acids Res., October 21, 2005; 33(19): e165 - e165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gu, M. R. Spitz, H. Zhao, J. Lin, H.B. Grossman, C. P. Dinney, and X. Wu Roles of tumor suppressor and telomere maintenance genes in cancer and aging--an epidemiological study Carcinogenesis, October 1, 2005; 26(10): 1741 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peluso, A. Munnia, G. Hoek, M. Krzyzanowski, F. Veglia, L. Airoldi, H. Autrup, A. Dunning, S. Garte, P. Hainaut, et al. DNA Adducts and Lung Cancer Risk: A Prospective Study Cancer Res., September 1, 2005; 65(17): 8042 - 8048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Ritchey, W.-Y. Huang, A. P. Chokkalingam, Y.-T. Gao, J. Deng, P. Levine, F. Z. Stanczyk, and A. W. Hsing Genetic Variants of DNA Repair Genes and Prostate Cancer: A Population-Based Study Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1703 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin, F. F. Kadlubar, M. R. Spitz, H. Zhao, and X. Wu A Modified Host Cell Reactivation Assay to Measure DNA Repair Capacity for Removing 4-Aminobiphenyl Adducts: A Pilot Study of Bladder Cancer Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1832 - 1836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wei, J. Lifen, H. Jiliang, L. Jianlin, W. Baohong, and D. Hongping Detecting DNA repair capacity of peripheral lymphocytes from cancer patients with UVC challenge test and bleomycin challenge test Mutagenesis, July 1, 2005; 20(4): 271 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kyoizumi, Y. Kusunoki, T. Hayashi, M. Hakoda, J. B. Cologne, and K. Nakachi Individual Variation of Somatic Gene Mutability in Relation to Cancer Susceptibility: Prospective Study on Erythrocyte Glycophorin A Gene Mutations of Atomic Bomb Survivors Cancer Res., June 15, 2005; 65(12): 5462 - 5469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Alberg, M. V. Brock, and J. M. Samet Epidemiology of Lung Cancer: Looking to the Future J. Clin. Oncol., May 10, 2005; 23(14): 3175 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Hung, P. Brennan, F. Canzian, N. Szeszenia-Dabrowska, D. Zaridze, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, L. Foretova, et al. Large-Scale Investigation of Base Excision Repair Genetic Polymorphisms and Lung Cancer Risk in a Multicenter Study J Natl Cancer Inst, April 20, 2005; 97(8): 567 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Chang, R. Komaki, R. Sasaki, Z. Liao, C. W. Stevens, C. Lu, F. V. Fossella, P. K. Allen, J. D. Cox, M. R. Spitz, et al. High Mutagen Sensitivity in Peripheral Blood Lymphocytes Predicts Poor Overall and Disease-Specific Survival in Patients with Stage III Non-Small Cell Lung Cancer Treated with Radiotherapy and Chemotherapy Clin. Cancer Res., April 15, 2005; 11(8): 2894 - 2898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Trenz, P. Schutz, and G. Speit Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis Mutagenesis, March 1, 2005; 20(2): 131 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Hong, A. Yeung, P. Funchain, M. M. Slupska, and J. H. Miller Mutants with Temperature-Sensitive Defects in the Escherichia coli Mismatch Repair System: Sensitivity to Mispairs Generated In Vivo J. Bacteriol., February 1, 2005; 187(3): 840 - 846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Berwick and P. Vineis Measuring DNA Repair Capacity: Small Steps J Natl Cancer Inst, January 19, 2005; 97(2): 84 - 85. [Full Text] [PDF]
|
|
|
|
|
|
D. O. Kennedy, M. Agrawal, J. Shen, M. B. Terry, F. F. Zhang, R. T. Senie, G. Motykiewicz, and R. M. Santella DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer J Natl Cancer Inst, January 19, 2005; 97(2): 127 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, J. A. Roth, H. Zhao, S. Luo, Y.-L. Zheng, S. Chiang, and M. R. Spitz Cell Cycle Checkpoints, DNA Damage/Repair, and Lung Cancer Risk Cancer Res., January 1, 2005; 65(1): 349 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peluso, M. Neri, G. Margarino, C. Mereu, A. Munnia, M. Ceppi, M. Buratti, R. Felletti, F. Stea, R. Quaglia, et al. Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms Carcinogenesis, December 1, 2004; 25(12): 2459 - 2465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Popanda, T. Schattenberg, C. T. Phong, D. Butkiewicz, A. Risch, L. Edler, K. Kayser, H. Dienemann, V. Schulz, P. Drings, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer Carcinogenesis, December 1, 2004; 25(12): 2433 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Schabath, H. B. Grossman, G. L. Delclos, L. M. Hernandez, R. S. Day, B. R. Davis, S. P. Lerner, M. R. Spitz, and X. Wu Dietary Carotenoids and Genetic Instability Modify Bladder Cancer Risk J. Nutr., December 1, 2004; 134(12): 3362 - 3369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|